{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:13:52Z","timestamp":1790741632263,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"DOI":"10.1007\/s13668-025-00610-x","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:04:20Z","timestamp":1736993060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nutrition and Huntington\u2019s Disease\u2013 A Review of Current Practice and Theory"],"prefix":"10.1007","volume":"14","author":[{"given":"Ann","family":"Gaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"610_CR1","unstructured":"Ajitkumar A, De Jesus O. Huntington Disease. StatPearls Publishing LLC. 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559166\/"},{"key":"610_CR2","doi-asserted-by":"publisher","unstructured":"Mestre T, et al. Therapeutic interventions for disease progression in Huntington\u2019s disease. Cochrane Database Syst Rev. 2009;3(CD006455). https:\/\/doi.org\/10.1002\/14651858.CD006455.pub2.","DOI":"10.1002\/14651858.CD006455.pub2"},{"key":"610_CR3","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/jnr.24492","volume":"97","author":"TO Tobore","year":"2019","unstructured":"Tobore TO. Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington\u2019s disease. J Neuro Res. 2019;97:1455\u201368. https:\/\/doi.org\/10.1002\/jnr.24492.","journal-title":"J Neuro Res"},{"issue":"4","key":"610_CR4","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s13311-020-00891-w","volume":"17","author":"D Dash","year":"2020","unstructured":"Dash D, Mestre TA. Therapeutic update on Huntington\u2019s Disease: symptomatic treatments and emerging Disease-Modifying therapies. Neurotherapeutics. 2020;17(4):1645\u201359. https:\/\/doi.org\/10.1007\/s13311-020-00891-w.","journal-title":"Neurotherapeutics"},{"key":"610_CR5","doi-asserted-by":"publisher","first-page":"15242","DOI":"10.1038\/s41598-020-72250-w","volume":"10","author":"A Schindler","year":"2020","unstructured":"Schindler A, et al. Fiberoptic endoscopic evaluation of swallowing in earlytoadvanced stage Huntington\u2019s disease. Sci Rep. 2020;10:15242. https:\/\/doi.org\/10.1038\/s41598-020-72250-w.","journal-title":"Sci Rep"},{"issue":"4","key":"610_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12603-022-1743-6","volume":"26","author":"K Kalkers","year":"2022","unstructured":"Kalkers K, et al. Dysphagia, fear of choking and preventive measures in patients with Huntington\u2019s Disease: the perspectives of patients and caregivers in long-term care. J Nutr Health Aging. 2022;26(4):332\u20138. https:\/\/doi.org\/10.1007\/s12603-022-1743-6. This study describes the impact of dysphagia and fear of swallowing for HD patients and caregivers.","journal-title":"J Nutr Health Aging"},{"key":"610_CR7","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1111\/ene.15345","volume":"29","author":"N Pizzorni","year":"2022","unstructured":"Pizzorni N, et al. Predictors of malnutrition risk in neurodegenerative diseases: the role of swallowing function. Eur J Neurol. 2022;29:2493\u20138. https:\/\/doi.org\/10.1111\/ene.15345.","journal-title":"Eur J Neurol"},{"key":"610_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1136\/jim-2018-000722","volume":"66","author":"M Borga","year":"2018","unstructured":"Borga M, et al. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018;66:887\u201395. https:\/\/doi.org\/10.1136\/jim-2018-000722.","journal-title":"J Investig Med"},{"key":"610_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.nut.2018.08.005","volume":"59","author":"R Costa de Miranda","year":"2019","unstructured":"Costa de Miranda R, et al. Body composition and bone mineral density in Huntington\u2019s disease. Nutrition. 2019;59:145\u20139. https:\/\/doi.org\/10.1016\/j.nut.2018.08.005.","journal-title":"Nutrition"},{"key":"610_CR10","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.prdoa.2020.100041","volume":"3","author":"AG Hamedani","year":"2020","unstructured":"Hamedani AG, et al. Inpatient gastrostomy in Huntington\u2019s disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis. Parkinsonism Relat Disord. 2020;3:100041. https:\/\/doi.org\/10.1016\/j.prdoa.2020.100041.","journal-title":"Parkinsonism Relat Disord"},{"key":"610_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14130","author":"M Farag","year":"2024","unstructured":"Farag M, et al. Outcomes of Percutaneous Endoscopic Gastrostomy in Huntington\u2019s Disease at a Tertiary Center. Move Disord Clin Pract. 2024. https:\/\/doi.org\/10.1002\/mdc3.14130. This study describes the impacts of tube feeding, pros and cons, in advanced HD patients.","journal-title":"Move Disord Clin Pract"},{"key":"610_CR12","doi-asserted-by":"publisher","first-page":"1800619","DOI":"10.1002\/mnfr.201800619","volume":"62","author":"M Aganzo","year":"2018","unstructured":"Aganzo M, et al. Customized dietary intervention avoids Unintentional Weight loss and modulates circulating miRNAs footprint in Huntington\u2019s Disease. Mol Nutr Food Res. 2018;62:1800619. https:\/\/doi.org\/10.1002\/mnfr.201800619.","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"610_CR13","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1001\/jamaneurol.2013.3487","volume":"70","author":"K Marder","year":"2013","unstructured":"Marder K, et al. Relationship of Mediterranean Diet and caloric intake to Phenoconversion in Huntington Disease. JAMA Neurol. 2013;70(11):1382\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2013.3487.","journal-title":"JAMA Neurol"},{"key":"610_CR14","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.3390\/nu12102946","volume":"12","author":"C Christodoulou","year":"2020","unstructured":"Christodoulou C, et al. Dietary intake, Mediterranean Diet adherence and caloric intake in Huntington\u2019s Disease. Rev Nutrients. 2020;12:2946. https:\/\/doi.org\/10.3390\/nu12102946.","journal-title":"Rev Nutrients"},{"key":"610_CR15","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/nu15051136","volume":"15","author":"CC Christodoulou","year":"2023","unstructured":"Christodoulou CC, et al. Investigating the Dietary Intake using the CyFFQ semi-quantitative food frequency questionnaire in Cypriot Huntington\u2019s Disease patients. Nutrients. 2023;15:1136. https:\/\/doi.org\/10.3390\/nu15051136.","journal-title":"Nutrients"},{"key":"610_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ypmed.2006.12.009","volume":"44","author":"DB Panagiotakos","year":"2007","unstructured":"Panagiotakos DB, et al. Adherence to the Mediterranean Food Pattern Predicts the Prevalence of Hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the Accuracy of the MedDietScore. Prev Med. 2007;44:335\u201340. https:\/\/doi.org\/10.1016\/j.ypmed.2006.12.009.","journal-title":"Prev Med"},{"key":"610_CR17","doi-asserted-by":"publisher","first-page":"e43134","DOI":"10.1371\/journal.pone.0043134","volume":"7","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2012","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA, et al. A 14-Item Mediterranean Diet Assessment Tool and obesity indexes among high-risk subjects: the PREDIMED Trial. PLoS ONE. 2012;7:e43134. https:\/\/doi.org\/10.1371\/journal.pone.0043134.","journal-title":"PLoS ONE"},{"issue":"2","key":"610_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cnp.2017.07.001","volume":"24","author":"JM Kim","year":"2017","unstructured":"Kim JM. Ketogenic diet: old treatment, new beginning. Clin Neurophysiol Pract. 2017;24(2):161\u20132. https:\/\/doi.org\/10.1016\/j.cnp.2017.07.001.","journal-title":"Clin Neurophysiol Pract"},{"issue":"13","key":"610_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnins.2019.00005","volume":"29","author":"I D\u2019Andrea Meira","year":"2019","unstructured":"D\u2019Andrea Meira I, et al. Ketogenic Diet and Epilepsy: what we know so far. Front Neurosci. 2019;29(13):5. https:\/\/doi.org\/10.3389\/fnins.2019.00005.","journal-title":"Front Neurosci"},{"key":"610_CR20","doi-asserted-by":"publisher","unstructured":"Jiang Z, et al. Effects of Ketogenic Diet on Neuroinflammation in neurodegenerative diseases. Aging Dis. 2022;13(4). https:\/\/doi.org\/10.14336\/AD.2021.1217.","DOI":"10.14336\/AD.2021.1217"},{"key":"610_CR21","doi-asserted-by":"publisher","unstructured":"Whittaker DS et al. Dietary ketosis improves circadian dysfunction as well as motor symptoms in the BACHD mouse model of Huntington\u2019s disease. Front. Nutr. 2022;9:1034743. https:\/\/doi.org\/10.3389\/fnut.2022.1034743. A ketogenic diet was found to improve sleep-wake cycle and motor symptoms in a mouse model of HD.","DOI":"10.3389\/fnut.2022.1034743"},{"issue":"6","key":"610_CR22","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00415-020-10334-3","volume":"268","author":"Z Voysey","year":"2021","unstructured":"Voysey Z, et al. The sleep and circadian problems of Huntington\u2019s disease: when, why and their importance. J Neurol. 2021;268(6):2275\u201383. https:\/\/doi.org\/10.1007\/s00415-020-10334-3.","journal-title":"J Neurol"},{"key":"610_CR23","doi-asserted-by":"publisher","first-page":"931636","DOI":"10.3389\/fnbeh.2022.931636","volume":"16","author":"MCL Phillips","year":"2022","unstructured":"Phillips MCL, et al. Time-Restricted Ketogenic Diet in Huntington\u2019s Disease: a Case Study. Front Behav Neurosci. 2022;16:931636. https:\/\/doi.org\/10.3389\/fnbeh.2022.931636.","journal-title":"Front Behav Neurosci"},{"key":"610_CR24","doi-asserted-by":"publisher","first-page":"107861","DOI":"10.1016\/j.pharmthera.2021.107861","volume":"226","author":"X-Y Mao","year":"2021","unstructured":"Mao X-Y, et al. Dietary nutrition for neurological disease therapy: current status and future directions. Pharmacol Therapeut. 2021;226:107861. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107861.","journal-title":"Pharmacol Therapeut"},{"key":"610_CR25","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.3390\/ijms21072618","volume":"21","author":"F Oppedisano","year":"2020","unstructured":"Oppedisano F, et al. The potential for natural antioxidant supplementation in the early stages of neurodegenerative disorders. Int J Mol Sci. 2020;21:2618. https:\/\/doi.org\/10.3390\/ijms21072618.","journal-title":"Int J Mol Sci"},{"key":"610_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/biomedicines9101284","volume":"9","author":"SN Rai","year":"2021","unstructured":"Rai SN, et al. The role of vitamins in neurodegenerative disease: an update. Biomedicines. 2021;9:1284. https:\/\/doi.org\/10.3390\/biomedicines9101284.","journal-title":"Biomedicines"},{"key":"610_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2021.1910592","author":"N Kedar","year":"2021","unstructured":"Kedar N, Prasad, Stephen C. Bondy. Can a Micronutrient Mixture Delay the onset and progression of symptoms of single-point mutation diseases? J Am Coll Nutr. 2021. https:\/\/doi.org\/10.1080\/07315724.2021.1910592.","journal-title":"J Am Coll Nutr"},{"key":"610_CR28","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.3390\/nu15194129","volume":"15","author":"H Lahoda Brodska","year":"2023","unstructured":"Lahoda Brodska H, et al. The role of micronutrients in Neurological disorders. Nutrients. 2023;15:4129. https:\/\/doi.org\/10.3390\/nu15194129.","journal-title":"Nutrients"},{"issue":"12","key":"610_CR29","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1176\/ajp.152.12.1771","volume":"152","author":"CE Peyser","year":"1995","unstructured":"Peyser CE, et al. Trial of d-alpha-tocopherol in Huntington\u2019s disease. Am J Psychiatry. 1995;152(12):1771\u20135. https:\/\/doi.org\/10.1176\/ajp.152.12.1771.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"610_CR30","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/archneur.65.12.1582","volume":"65","author":"Huntington Study Group TREND-HD Investigators","year":"2008","unstructured":"Huntington Study Group TREND-HD Investigators. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol. 2008;65(12):1582\u20139. https:\/\/doi.org\/10.1001\/archneur.65.12.1582.","journal-title":"Arch Neurol"},{"issue":"10","key":"610_CR31","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/mds.26308","volume":"30","author":"JJ Ferreira","year":"2015","unstructured":"Ferreira JJ, et al. Ethyl-eicosapentaenoic acid treatment in Huntington\u2019s disease: a placebo-controlled clinical trial. Mov Disord. 2015;30(10):1426\u20139. https:\/\/doi.org\/10.1002\/mds.26308.","journal-title":"Mov Disord"},{"key":"610_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1212\/wnl.57.3.397","volume":"57","author":"The Huntington Study Group","year":"2001","unstructured":"The Huntington Study Group. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology. 2001;57:397\u2013404. https:\/\/doi.org\/10.1212\/wnl.57.3.397.","journal-title":"Neurology"},{"issue":"2","key":"610_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1212\/WNL.0000000000003478","volume":"88","author":"A McGarry","year":"2017","unstructured":"McGarry A, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017;88(2):152\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000003478.","journal-title":"Neurology"},{"issue":"6","key":"610_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1212\/WNL.0000000000004209","volume":"89","author":"SM Hersch","year":"2017","unstructured":"Hersch SM, For the Huntington Study Group CREST-E Investigators and Coordinators, et al. The CREST-E study of Creatine for Huntington disease\u2013 a randomized controlled trial. Neurology. 2017;89(6):594\u2013601. https:\/\/doi.org\/10.1212\/WNL.0000000000004209.","journal-title":"Neurology"},{"key":"610_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.15406\/japlr.2018.07.00256","volume":"7","author":"F Khan","year":"2018","unstructured":"Khan F, et al. Role of free radicals and certain antioxidants in the management of Huntington\u2019s disease: a review. J Anal Pharm Res. 2018;7:386\u201392. https:\/\/doi.org\/10.15406\/japlr.2018.07.00256.","journal-title":"J Anal Pharm Res"},{"key":"610_CR36","doi-asserted-by":"publisher","first-page":"922232","DOI":"10.3389\/fphar.2022.922232","volume":"13","author":"E Yadav","year":"2022","unstructured":"Yadav E, et al. Resveratrol: a potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction. Front Pharmacol. 2022;13:922232. https:\/\/doi.org\/10.3389\/fphar.2022.922232.","journal-title":"Front Pharmacol"},{"key":"610_CR37","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3390\/molecules27103297","volume":"27","author":"A Iftikhar","year":"2022","unstructured":"Iftikhar A, et al. Potential therapeutic benefits of Honey in Neurological disorders: the role of polyphenols. Molecules. 2022;27:3297. https:\/\/doi.org\/10.3390\/molecules27103297.","journal-title":"Molecules"},{"issue":"1","key":"610_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2991\/efood.k.200203.001","volume":"1","author":"H Khan","year":"2020","unstructured":"Khan H, et al. Dietary flavonoids in the management of Huntington\u2019s disease: mechanism and clinical perspective. EFood. 2020;1(1):3. https:\/\/doi.org\/10.2991\/efood.k.200203.001.","journal-title":"EFood"},{"key":"610_CR39","doi-asserted-by":"publisher","unstructured":"Talebi S, et al. Does hazelnut consumption affect brain health and function against neurodegenerative diseases? Nutr. Neurosci. 2023;1\u201317. https:\/\/doi.org\/10.1080\/1028415X.2023.2296164.","DOI":"10.1080\/1028415X.2023.2296164"},{"key":"610_CR40","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/ptr.8122","volume":"38","author":"R Kakarla","year":"2024","unstructured":"Kakarla R, et al. Current understanding and future directions of cruciferous vegetables and their phytochemicals to combat neurological diseases. Phytother Res. 2024;38:1381\u201399. https:\/\/doi.org\/10.1002\/ptr.8122.","journal-title":"Phytother Res"},{"key":"610_CR41","doi-asserted-by":"publisher","unstructured":"Cordeiro L et al. Neuroprotective effects of rutin on ASH neurons in Caenorhabditis elegans model of Huntington\u2019s disease. Nutrit Neurosci;25(11):2288\u2013301 https:\/\/doi.org\/10.1080\/1028415X.2021.1956254","DOI":"10.1080\/1028415X.2021.1956254"},{"issue":"3","key":"610_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/1028415X.2018.1484021","volume":"23","author":"J Varga","year":"2020","unstructured":"Varga J, et al. Green tea infusion alleviates neurodegeneration induced by mutant huntingtin in Drosophila. Nutrit Neurosci. 2020;23(3):183\u20139. doi10.1080\/1028415X.2018.1484021.","journal-title":"Nutrit Neurosci"},{"key":"610_CR43","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3390\/nu11102426","volume":"11","author":"F Di Meo","year":"2019","unstructured":"Di Meo F, et al. Curcumin, Gut Microbiota, and Neuroprotection. Nutrients. 2019;11:2426. https:\/\/doi.org\/10.3390\/nu11102426.","journal-title":"Nutrients"},{"issue":"23","key":"610_CR44","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1093\/hmg\/ddz247","volume":"28","author":"F Elifani","year":"2019","unstructured":"Elifani F, et al. Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington\u2019s disease. Hum Mol Genet. 2019;28(23):4012\u201321. https:\/\/doi.org\/10.1093\/hmg\/ddz247.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"610_CR45","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/1028415X.2020.1841500","volume":"25","author":"J Malik","year":"2022","unstructured":"Malik J, et al. Neuroprotective effect of standardized extracts of three Lactuca sativa Linn. Varieties against 3-NP induced Huntington\u2019s disease like symptoms in rats. Nutrit Neurosci. 2022;25(6):1173\u201387. https:\/\/doi.org\/10.1080\/1028415X.2020.1841500.","journal-title":"Nutrit Neurosci"},{"key":"610_CR46","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1039\/d3fo00156c","volume":"14","author":"N Yan","year":"2023","unstructured":"Yan N, et al. Neuroprotective effect of aloe emodin against Huntington\u2019s disease-like symptoms in R6\/1 transgenic mice. Food Funct. 2023;14:5205. https:\/\/doi.org\/10.1039\/d3fo00156c.","journal-title":"Food Funct"},{"key":"610_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147444","author":"MH Moghaddam","year":"2021","unstructured":"Moghaddam MH, et al. Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of Huntington disease. Brain Res. 2021. https:\/\/doi.org\/10.1016\/j.brainres.2021.147444. 1762.147444.","journal-title":"Brain Res"},{"key":"610_CR48","doi-asserted-by":"publisher","unstructured":"Boasqu\u00edvis PF, et al. Guarana (Paullinia cupana) Extract protects Caenorhabditis elegans models for Alzheimer Disease and Huntington Disease through activation of antioxidant and protein degradation pathways. Ox Med Cell Longev. 2018;9241308. https:\/\/doi.org\/10.1155\/2018\/9241308.","DOI":"10.1155\/2018\/9241308"},{"key":"610_CR49","doi-asserted-by":"publisher","first-page":"179e82","DOI":"10.1016\/j.nbd.2013.05.013","volume":"58","author":"C Simonin","year":"2013","unstructured":"Simonin C, et al. Association between caffeine intake and age at onset in Huntington\u2019s disease. Neurobiol Dis. 2013;58:179e82. https:\/\/doi.org\/10.1016\/j.nbd.2013.05.013.","journal-title":"Neurobiol Dis"},{"key":"610_CR50","doi-asserted-by":"publisher","unstructured":"Wang M, et al. Mendelian randomization study of coffee consumption and age at onset of Huntington\u2019s disease. Clin Nutr. 2021;40(5615e5618). https:\/\/doi.org\/10.1016\/j.clnu.2021.09.041. A mendelian randomization showed a causal relationship between higher coffee intake and earlier age of onset of HD symptoms.","DOI":"10.1016\/j.clnu.2021.09.041"},{"key":"610_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054477","author":"D Wronka","year":"2023","unstructured":"Wronka D, et al. What the Gut tells the Brain\u2014Is there a link between Microbiota and Huntington\u2019s Disease? Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054477. 24.4477.","journal-title":"Int J Mol Sci"},{"key":"610_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17102","author":"MN Ekwudo","year":"2024","unstructured":"Ekwudo MN. The microbiota\u2013gut\u2013brain axis in Huntington\u2019s disease: pathogenic mechanisms and therapeutic targets. FEBS J. 2024. https:\/\/doi.org\/10.1111\/febs.17102.","journal-title":"FEBS J"},{"key":"610_CR53","doi-asserted-by":"publisher","unstructured":"Wasser CI, et al. Gut dysbiosis in Huntington\u2019s disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun. 2020;1\u201313. https:\/\/doi.org\/10.1093\/braincomms\/fcaa110.","DOI":"10.1093\/braincomms\/fcaa110"},{"key":"610_CR54","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/nu13051655","volume":"13","author":"P Cronin","year":"2021","unstructured":"Cronin P, et al. Dietary Fibre modulates the gut microbiota. Nutrients. 2021;13:1655. https:\/\/doi.org\/10.3390\/nu13051655.","journal-title":"Nutrients"},{"key":"610_CR55","doi-asserted-by":"publisher","first-page":"954845","DOI":"10.3389\/fimmu.2022.954845","volume":"13","author":"M-L Puhlmann","year":"2022","unstructured":"Puhlmann M-L, de Vos WM. Intrinsic dietary fibers and the gut microbiome: rediscovering the benefits of the plant cell matrix for human health. Front Immunol. 2022;13:954845. https:\/\/doi.org\/10.3389\/fimmu.2022.954845.","journal-title":"Front Immunol"},{"key":"610_CR56","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bbi.2023.12.023","volume":"116","author":"C Gubert","year":"2024","unstructured":"Gubert C, et al. Dietary fibre confers therapeutic effects in a preclinical model of Huntington\u2019s disease. Brain Behav Immun. 2024;116:404\u201318. https:\/\/doi.org\/10.1016\/j.bbi.2023.12.023. A high fiber diet showed benefit in a mouse model of HD, potentially through modification of the gut microbiome.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"610_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2217\/fnl-2017-0035","volume":"13","author":"KT Potkin","year":"2018","unstructured":"Potkin KT, Potkin SG. New directions in therapeutics for Huntington disease. Future Neurol. 2018;13(2):101\u201321. https:\/\/doi.org\/10.2217\/fnl-2017-0035.","journal-title":"Future Neurol"},{"key":"610_CR58","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature01626","volume":"422","author":"FS Collins","year":"2003","unstructured":"Collins FS, et al. A vision for the future of genomics research. Nature. 2003;422:835\u201347. https:\/\/doi.org\/10.1038\/nature01626.","journal-title":"Nature"},{"key":"610_CR59","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.3390\/ijms21197414","volume":"21","author":"CC Christodoulou","year":"2020","unstructured":"Christodoulou CC, et al. Investigating the transition of Pre-symptomatic to Symptomatic Huntington\u2019s Disease Status based on Omics Data. Int J Mol Sci. 2020;21:7414. https:\/\/doi.org\/10.3390\/ijms21197414.","journal-title":"Int J Mol Sci"},{"key":"610_CR60","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/metabo13121203","volume":"13","author":"S Akyol","year":"2023","unstructured":"Akyol S, et al. Metabolomics: an emerging Omics platform for systems Biology and its implications for Huntington Disease Research. Metabolites. 2023;13:1203. https:\/\/doi.org\/10.3390\/metabo13121203. This review describes the potential of metabolomics methods to enhance HD research.","journal-title":"Metabolites"},{"key":"610_CR61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s13205-023-03525-y","volume":"13","author":"SS Pradhan","year":"2023","unstructured":"Pradhan SS, et al. Vitamin B6, B12 and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington disease. 3 Biotech. 2023;13:96. https:\/\/doi.org\/10.1007\/s13205-023-03525-y.","journal-title":"3 Biotech"},{"key":"610_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3390\/nu14081577","volume":"14","author":"RD Russell","year":"2022","unstructured":"Russell RD, et al. Nutrition Education Programs for adults with neurological diseases are lacking: a scoping review. Nutrients. 2022;14:1577. https:\/\/doi.org\/10.3390\/nu14081577.","journal-title":"Nutrients"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-025-00610-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-025-00610-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-025-00610-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:04:26Z","timestamp":1736993066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-025-00610-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1007\/s13668-025-00610-x","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"6 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies of human or animal subjects performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"18"}}